ClinicalTrials.Veeva

Menu

Hypercapnic Acute Respiratory Failure in the ICU : the YETI Study

F

French Society for Intensive Care

Status

Completed

Conditions

Hypercapnia
Acute Respiratory Failure
Intensive Care Unit Syndrome

Treatments

Other: Hypercapnic respiratory failure

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Hypercapnia is a frequent clinical situation defined as an elevation of the partial pressure of carbon dioxide (PaCO2) above 45 mmHg. Several physiopathological parameters such as respiratory minute volume, dead space volume or CO2 production influence the PaCO2. Therefore, hypercapnia can affect the time of various diseases.

Available epidemiological data regarding hypercapnia are from studies investigating the efficacy of non-invasive ventilation (NIV), with different population cohorts. However, their interpretation must be cautious given the heterogeneity in patient case-mix and results.

Then, whether hypercapnia is a common reason for intensive care unit (ICU) admission, epidemiological data is scarce and heterogeneous. The aim of this study is to investigate the epidemiological, clinical determinants and outcomes of patients admitted to ICU with hypercapnic respiratory failure.

Enrollment

862 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients ≥18 years old presenting with at least of the following items :

    1. respiratory rate ≥ 25/min,
    2. paradoxical motion of the abdomen,
    3. intercostal retraction AND
  • a PaCO2 > 45 cm H20 before ICU admission or within the 12 hours following ICU admission.

Exclusion criteria

  • Refusal to give informed consent,
  • pregnancy,
  • < 18 years patient,
  • dying patient

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems